Factors Predicting the Off-treatment Duration in Patients with Prostate Cancer Receiving Degarelix as Intermittent Androgen Deprivation Therapy

Factors Predicting the Off-treatment Duration in Patients with Prostate Cancer Receiving Degarelix as Intermittent Androgen Deprivation Therapy

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: European Urology Focus - Volume 3, Issues 4–5, October 2017, Pages 470-479

Per-Anders Abrahamsson, Laurent Boccon-Gibod, Juan Morote, Igle Jan de Jong, Anders Malmberg, Anders Neijber, Peter Albers,